In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T

Magnetic Resonance in Medicine

Volumn 72, Issue 2, 2014, Pages 316-323

  Choi, Changho ^a,b   Ganji, Sandeep K ^a   Madan, Akshay ^a   Hulsey, Keith M ^a   An, Zhongxu ^a   Zhang, Song ^a   Pinho, Marco C ^a   Deberardinis, Ralph J ^a   Bachoo, Robert M ^a,b,c   Maher, Elizabeth A ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

3T; adults; citrate; density matrix simulation; gliomas; PRESS (point resolved spectroscopy)

Indexed keywords

MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; PRESSES (MACHINE TOOLS);

ADULTS; CITRATE; DENSITY MATRIX; GLIOMAS; POINT RESOLVED SPECTROSCOPIES;

TUMORS;

CITRIC ACID; WATER; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; OLIGODENDROGLIOMA; POINT RESOLVED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; SPECTROSCOPY; BRAIN CHEMISTRY; CHEMISTRY; FEMALE; GLIOMA; MALE; MIDDLE AGED; MOLECULAR IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CITRIC ACID; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; MOLECULAR IMAGING; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84904498539     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24946     Document Type: Article

References (25)

1. Mullen AR, Wheaton WW, Jin ES, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012; 481: 385-388.
2. Icard P, Poulain L, Lincet H,. Understanding the central role of citrate in the metabolism of cancer cells. Biochim Biophys Acta 2012; 1825: 111-116.
3. Moore GJ, Sillerud LO,. The pH dependence of chemical shift and spin-spin coupling for citrate. J Magn Reson B 1994; 103: 87-88.
4. Barker PB, Bizzi A, De Stefano N, Gullapalli RP, Lin DDM,. Clinical MR Spectroscopy: Techniques and Applications. Cambridge, UK: Cambridge University Press; 2010.
5. Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011; 261: 46-66.
6. Seymour ZA, Panigrahy A, Finlay JL, Nelson MD Jr, Bluml S,. Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol 2008; 29: 1006-1011.
7. Bluml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, Finlay JL, Gilles FH,. Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol 2011; 13: 1107-1117.
8. Govindaraju V, Young K, Maudsley AA,. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129-153.
9. 1H MR spectroscopy. J Magn Reson 2008; 195: 67-75.
10. 1H MRS at 7 T. NMR Biomed 2010; 23: 1044-1052.
11. 1H-MRSI of the human brain at 7 T with minimal signal loss. NMR Biomed 2009; 22: 683-696.
12. 1H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed 2013; 26: 1242-1250.
13. Gruetter R,. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993; 29: 804-811.
14. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
15. Ganji SK, Banerjee A, Patel AM, Zhao YD, Dimitrov IE, Browning JD, Brown ES, Maher EA, Choi C,. T2 measurement of J-coupled metabolites in the human brain at 3T. NMR Biomed 2012; 25: 523-529.
16. Scheenen TW, Gambarota G, Weiland E, Klomp DW, Futterer JJ, Barentsz JO, Heerschap A,. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med 2005; 53: 1268-1274.
17. Madan A, Ganji SK, Maher EA, Choi C,. Measurement of transverse relaxation times in brain tumors. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. p. 1997.
18. Ernst RR, Bodenhausen G, Wokaun A,. Principles of nuclear magnetic resonance in one and two dimensions. Oxford, UK: Clarendon Press; 1987.
19. Choi C, Ganji SK, Deberardinis RJ, et al. 2-Hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 2012; 18: 624-629.
20. 13C NMR spectra of N-acetylaspartylglutamate and its detection in urine from patients with Canavan disease. J Pharm Biomed Anal 2003; 31: 455-463.
21. Wright AJ, Fellows GA, Griffiths JR, Wilson M, Bell BA, Howe FA,. Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer 2010; 9: 66.
22. Ashoori I, Panigrahy A, Nagasunder A, Dhall G, Nelson MD, Blüml S,. Dynamic proton MRS in pediatric brain tumors with prominent citrate. In Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. p. 1777.
23. 13C-NMR spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem J 1990; 266: 133-139.
24. 13C-NMR study. Biochem J 1992; 282: 225-230.
25. 13C-MRS studies on cerebral metabolism. MAGMA 1994; 2: 285-289.